Table 1.
Reference | Type of Intervention | Study Design | Number of Patients Treated | Number of Sites (Implants/Teeth) Treated | Follow-Up | Outcomes | Complications |
---|---|---|---|---|---|---|---|
Crespi et al., 2012 A [19] | Sinus lift | Prospective | 40 MM 40 CTR |
60 MM 60 CTR |
6, 12, 24 m | Survival rate of 98.33% (both groups) | 2 BPPV in CTR group |
Crespi et al., 2012 B [20] | Implant site preparation | Prospective | 25 MM 25 CTR |
69 MM 69 CTR |
6, 12, 24 m | Survival rate of 97.1% (MM) and 92.75% (CTR) | 2 BPPV in CTR group |
Crespi et al., 2013 A [21] | Sinus lift | Prospective | 32 | 70 | 2, 4, 12, 24 m | Survival rate of 98.57% | - |
Crespi et al., 2013 B [22] | Implant site preparation | Prospective | 18 MM 18 CTR |
25 MM 25 CTR |
6, 12, 24 m | Survival rate of 96% (both groups) | 2 BPPV in CTR group |
Crespi et al., 2014 A [23] | Ridge expansion | Prospective | 23 MM 23 CTR |
59 MM 59 CTR |
6, 12, 24 m | Survival rate of 100% (MM) and 96.61% (CTR) | 1 BPPV in CTR group |
Crespi et al., 2014 B [24] | Dental extraction | Retrospective | 156 | 427 | - | No fracture or loss of cortical bone plate | - |
Crespi et al., 2015 [25] | Ridge expansion | Retrospective | 36 | 93 | 6, 12, 24 m | Survival rate of 98.92% | - |
Crespi et al., 2016 A [26] | Implant site preparation | Prospective | 40 | 40 | 36 m | Survival rate of 100% | - |
Crespi et al., 2016 B [27] | Implant site preparation | Prospective | 57 | 84 | 36 m | Survival rate of 100% | - |
Crespi et al., 2017 [28] * | Dental extraction | Prospective | 53 | 145 | 3 m | No signs of inflamed tissue or exposed bone | - |
Menchini-Fabris GB, et al. 2020 A [29] * | Dental extraction | Retrospective | 47 | 47 | 24–36 m | No postoperative complications | - |
Menchini-Fabris GB, et al. 2020 B [30] | Sinus lift | Observational | 29 MM 27 CTR |
29 MM 27 CTR |
36 m | Survival rate of 100% (MM) and 92.6% (CTR) | - |
Crespi et al. 2021 [31] | Sinus lift | Retrospective | 40 | 40 | 36 m | Survival rate 100% | - |
Bruschi et al. 2021 [32] | Sinus lift | Retrospective | 52 | 71 | 9–66 m (mean 29.8 m) | Survival rate 98.6% | - |
Legend: MM, magnetic mallet; CTR, control group; m, months; BPPV, benign paroxysmal positional vertigo. * MM was not the main topic investigated in the manuscript.